Signalomic signatures enlighten drug profiling.
Abraham
Robert T
RT
D001426:Bacterial Proteins / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D016000:Cluster Analysis; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D015507:Drugs, Investigational / Q000494:pharmacology*; D006801:Humans; D008164:Luminescent Proteins / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D008954:Models, Biological; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D013329:Structure-Activity Relationship
D001426:Bacterial Proteins; D015507:Drugs, Investigational; D008164:Luminescent Proteins; D011993:Recombinant Fusion Proteins; C054562:yellow fluorescent protein, Bacteria